Salvador Gil-Vernet
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients (NCT00730769) | Salvador Gil-Vernet | 2004-03-01 |
Track Salvador Gil-Vernet automatically
Every clearance here is in the API, with alerts when new ones post.